Safety of Long-Acting β-Agonists

  1. Graeme P. Currie, MD
  1. From Aberdeen Royal Infirmarya, Aberdeen, Scotland, United Kingdom.

    TO THE EDITOR:

    The meta-analysis by Salpeter and colleagues (1) raises concerns over the long-term safety of LABAs in patients with asthma. However, the authors are incorrect in stating that “[i]f long-acting β-agonists were removed …

    [Full Text of this Article]
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med November 7, 2006 vol. 145 no. 9 707-708
    1. » Excerpt
    2. Full Text
    3. Full Text (PDF)

    Rapid Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. December 1, 2009, 151 (11)
    1. Alert me to current issues